Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder

NARecruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

May 1, 2026

Study Completion Date

September 1, 2026

Conditions
Obsessive-Compulsive DisorderPsychiatric Disorder
Interventions
DEVICE

Implantation of a DBS therapy system

"The system is called Reclaim DBS Therapy for OCD und is marketed by Medtronic (Minneapolis, Minnesota). It has a HDE status by the FDA. The system consists of two quadripolar electrodes (Medtronic Reclaim DBS) as well as a generator (Medtronic Activa PC), which will be implanted into a subcutaneous pocket below the clavicula."

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER